Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 319-333
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Group | Corrected cognitive impairment | Cognitive ability | Others’ evaluation | Impact on quality of life |
Experimental group (n = 27) | ||||
Baseline | 47.19 ± 4.14 | 14.96 ± 3.47 | 10.93 ± 2.24 | 8.81 ± 2.08 |
3 mo | 50.26 ± 3.96b,e | 17.11 ± 3.64b,d | 11.26 ± 2.33a | 9.37 ± 2.66e |
6 mo | 54.22 ± 6.80b,c,e | 18.30 ± 4.26b,c,e | 12.22 ± 2.28b,c,e | 10.81 ± 2.73b,c,e |
Control group (n = 28) | ||||
Baseline | 46.07 ± 5.73 | 14.57 ± 2.87 | 10.11 ± 2.25 | 7.71 ± 1.94 |
3 mo | 46.21 ± 5.37 | 14.68 ± 3.22 | 10.14 ± 2.17 | 7.32 ± 2.02 |
6 mo | 46.25 ± 6.92 | 14.86 ± 3.50 | 10.21 ± 2.35 | 7.43 ± 2.01 |
- Citation: Lin ZG, Li RD, Ai FL, Li S, Zhang XA. Effects of cognitive behavior therapy combined with Baduanjin in patients with colorectal cancer . World J Gastrointest Oncol 2022; 14(1): 319-333
- URL: https://www.wjgnet.com/1948-5204/full/v14/i1/319.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i1.319